Scrip Podcasts
Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.
2 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Scrip Podcasts community!